Giugliano, Dario
Longo, Miriam
Signoriello, Simona
Maiorino, Maria Ida
Solerte, Bruno
Chiodini, Paolo
Esposito, Katherine
Article History
Received: 17 January 2022
Accepted: 24 February 2022
First Online: 16 March 2022
Declarations
:
: Not applicable.
: Not applicable.
: DG received honoraria for speaking at meetings from Novartis, Sanofi, Eli Lilly and Company, AstraZeneca, and Novo Nordisk. MIM received honoraria for speaking at meetings from AstraZeneca, Novo Nordisk, Bruno Farmaceutici, Mundipharma, and Sanofi. KE received honoraria for speaking at meetings from Novartis, Sanofi Aventis, Eli Lilly and Company, AstraZeneca, Boehringer Ingelheim, and Novo Nordisk. No other potential conflicts of interest relevant to this article were reported.